ABSTRACT
The purpose of this investigation was to elucidate the regulation of inducible nitric oxide synthase (iNOS) expression by vascular endothelial growth factor (VEGF) in a muscle flap ischemia model in rats. The gracilis muscle flap model was chosen. Sixty adult male Sprague Dawley rats were randomly divided into two groups (n = 30). After 4 hours ischemia, the experimental group received VEGF treatment, and the control group was given saline in the same fashion. At time intervals of 0, 2, 6, 12, and 18 hours (n = 6 for each time interval) after injection, tissue samples were biopsied for reverse transcriptase polymerase chain reaction, routine hematoxylin-eosin staining, and CD31 immunohistochemical staining. The result showed that iNOS expression is increased in the gracilis muscle flap ischemia model in rats compared with the control group within 6 hours after ischemia (p < 0.05). In the VEGF group, iNOS expression increased rapidly over the first 2 hours, but no statistically significant difference was observed at 12 and 18 hours between the two groups (p > 0.05). We concluded that the application of VEGF could maintain the structure of capillaries and upregulate iNOS expression during the first 6 hours after ischemia in the ischemic muscle flap of a rat model. These findings may provide the evidence to study the mechanism of VEGF in improving flap survival.
KEYWORDS
Vascular endothelial growth factor - inducible nitric oxide synthase - muscle flap
REFERENCES
-
1
Lineaweaver W C, Buncke H J, Whitney T M, Clapson J B, Buncke G M, Alpert B S.
Factors associated with microvascular flap failure and direction for research.
Plast Surg Forum.
1989;
12
252-253
-
2
Hallock G G.
Is there a “learning curve” for muscle perforator flaps?.
Ann Plast Surg.
2008;
60
146-149
-
3
De Santis G, Pinelli M.
Microsurgical model of ischemia reperfusion in rat muscle: evidence of free radical formation by spin trapping.
Microsurgery.
1994;
15
655-659
-
4
Morris S F, Pang C Y, Zhong A et al..
Assessment of ischemia-induced reperfusion injury in the pig latissimus dorsi myocutaneous flap model.
Plast Reconstr Surg.
1993;
92
1162-1172
-
5
Pu L Q, Gadowski G R, Graham A M et al..
Enhanced revascularisation after angiogenic stimulation in a rabbit model of bilateral limb ischaemia.
Eur J Vasc Endovasc Surg.
1995;
9(2)
189-196
-
6
Lefer A M, Ma X L, Weyrich A S, Scalia R.
Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.
Proc Natl Acad Sci U S A.
1993;
90(3)
1018-1022
-
7
Kenny D, Coughlan M G, Pagel P S, Kampine J P, Warltier D C.
Transforming growth factor beta 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion.
Am Heart J.
1994;
127(6)
1456-1461
-
8
Antonini A, Zacchigna S, Papa G, Novati F, Pascone M, Giacca M.
Improved survival of rat ischemic cutaneous and musculocutaneous flaps after VEGF gene transfer.
Microsurgery.
2007;
27
439-445
-
9
Frangoulis M, Georgiou P, Chrisostomidis C et al..
Rat epigastric flap survival and VEGF expression after local copper application.
Plast Reconstr Surg.
2007;
119
837-843
-
10
Zhang F, Brooks D, Chen W, Mustain W, Chen M B, Lineaweaver W C.
Improvement of venous flap survival by application of vascular endothelial growth factor in a rat model.
Ann Plast Surg.
2006;
56
670-673
-
11
Zhang F, Yang F, Hu E C, Sones W, Lei M, Lineaweaver W C.
Vascular endothelial growth factor gene therapy in improvement of skin paddle survival in a rat TRAM flap model.
J Reconstr Microsurg.
2005;
21
391-396
-
12 Yim K, Lineaweaver W, Briones R et al.. Critical ischemia time of rat serratus anterior and gracilis muscles. In: Carraro U, Salmon S Basic and Applied Myology: Perspectives for the 90's. Padova, Italy; Unipress 1991: 373
-
13
Kryger Z, Dogan T, Zhang F et al..
Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat.
Ann Plast Surg.
1999;
43
172-178
-
14
Tzeng E, Kim Y M, Pitt B R, Lizonova A, Kovesdi I, Billiar T R.
Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis.
Surgery.
1997;
122(2)
255-263
-
15
Flamme I, von Reutern M, Drexler H C, Syed-Ali S, Risau W.
Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.
Dev Biol.
1995;
171
399-414
-
16
Hippenstiel S, Krull M, Ikemann A, Risau W, Clauss M, Suttorp N.
VEGF induces hyperpermeability by a direct action on endothelial cells.
Am J Physiol.
1998;
274
L678-L684
-
17
Yang R, Thomas G R, Bunting S et al..
Effects of vascular endothelial growth factor on hemodynamics and cardiac performance.
J Cardiovasc Pharmacol.
1996;
27
838-844
-
18
Zachary I.
Vascular endothelial growth factor.
Int J Biochem Cell Biol.
1998;
30(11)
1169-1174
-
19
Takeshita S, Zheng L P, Brogi E et al..
Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.
J Clin Invest.
1994;
93
662-670
-
20
Bauters C, Asahara T, Zheng L P et al..
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor.
Circulation.
1995;
91
2802-2809
-
21
Becit N, Ceviz M, Kocak H et al..
The effect of vascular endothelial growth factor on angiogenesis: an experimental study.
Eur J Vasc Endovasc Surg.
2001;
22
310-316
-
22
Walder C E, Errett C J, Bunting S et al..
Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia.
J Cardiovasc Pharmacol.
1996;
27
91-98
-
23
Harada K, Friedman M, Lopez J J et al..
Vascular endothelial growth factor administration in chronic myocardial ischemia.
Am J Physiol.
1996;
270
H1791-H1802
-
24
Lopez J J, Laham R J, Stamler A et al..
VEGF administration in chronic myocardial ischemia in pigs.
Cardiovasc Res.
1998;
40
272-281
-
25
Padubidri A, Browne Jr E.
Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat.
Ann Plast Surg.
1996;
37
604-611
-
26
Seify H, Bulky U, Jones G.
Effect of vascular endothelial growth factor-induced angiogenesis on TRAM flap harvesting after abdominoplasty.
Plast Reconstr Surg.
2003;
111
1212-1216
-
27
Gurunluoglu R, Meirer R, Shafighi M, Huemer G M, Yilmaz B, Piza-Katzer H.
Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication.
Microsurgery.
2005;
25(5)
433-441
-
28
Neumeister M W, Song Y H, Mowlavi A, Suchy H, Mathur A.
Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracilis muscle.
Microsurgery.
2001;
21(2)
58-62
-
29
Banbury J, Siemionow M, Porvasnik S, Petras S, Browne E.
Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor.
Plast Reconstr Surg.
2000;
106(7)
1541-1546
-
30
Khan A, Ashrafpour H, Huang N et al..
Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and mechanism.
Am J Physiol Regul Integr Comp Physiol.
2004;
287
R1219-R1229
-
31
Papapetropoulos A, Garcia-Cardena G, Madri J A, Sessa W C.
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
J Clin Invest.
1997;
100
3131-3139
-
32
Krum J M, Mani N, Rosenstein J M.
Angiogenic and astroglial response to vascular endothelial growth factor administration in adult rat brain.
Neuroscience.
2002;
110
589-604
-
33
Pettersson A, Nagy J A, Brown C S et al..
Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular growth factor.
Lab Invest.
2000;
80
99-115
-
34
Angel M F, Ramasastry S S, Swartz W M et al..
The critical relationship between free radicals and degrees of ischemia: evidence for tissue intolerance of marginal perfusion.
Plast Reconstr Surg.
1988;
81
233-239
-
35
Kerrigan C L, Daniel R K.
Critical ischemic time and the failing skin flap.
Plast Reconstr Surg.
1982;
69
986-989
-
36
May J W, Chait L A, O'Brien B M, Hurley J V.
The no-reflow phenomenon in experimental free flaps.
Plast Reconstr Surg.
1978;
61
256-267
-
37
Milton S H.
Experimental studies on island flaps: ischemia and delay.
Plast Reconstr Surg.
1972;
49
444-447
-
38
Selye H.
Ischemic necrosis: prevention by stress.
Science.
1967;
156
1262-1263
-
39
Willms-Kretschmer K, Majno G.
Ischemia of the skin: electron microscopic study of vascular injury.
Am J Pathol.
1969;
54
327-353
-
40
Strock P E, Majno G.
Microvascular changes in acutely ischemic rat muscle.
Surg Gynecol Obstet.
1969;
129(6)
1213-1224
-
41
Gordon L, Buncke H J, Townsend J J.
Histological changes in skeletal muscle after temporary independent occlusion of arterial and venous supply.
Plast Reconstr Surg.
1978;
61(4)
576-579
-
42
Erdmann D, Sweis R, Wong M S et al..
Vascular endothelial growth factor expression in pig latissimus dorsi myocutaneous flaps after ischemia reperfusion injury.
Plast Reconstr Surg.
2003;
111(2)
775-780
-
43
Patel P, Qi W N, Allen D M et al..
Inhibition of iNOS with 1400W improves contractile function and alters nos gene and protein expression in reperfused skeletal muscle.
Microsurgery.
2004;
24
324-331
-
44
Wang W Z, Fang X H, Stepheson L L, Khiabani K T, Zamboni W A.
Acute microvascular action of vascular endothelial growth factor in skeletal muscle ischemia/reperfusion injury.
Plast Reconstr Surg.
2005;
115
1355-1365
-
45
Huang N, Khan A, Ashrafpour H et al..
Efficacy and mechanism of adenovirus-mediated VEGF-165 gene therapy for augmentation of skin flap viability.
Am J Physiol Heart Circ Physiol.
2006;
291
H127-H137
-
46
Ashrafpour H, Huang N, Neligan P C et al..
Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature.
Am J Physiol Heart Circ Physiol.
2004;
286
H946-H955
-
47
Kreidstein M L, Pang C Y, Carlsen L N, Xu N.
Evidence for endothelium-dependent and endothelium-independent vasodilation in human skin flaps.
Can J Physiol Pharmacol.
1992;
70
1208-1216
-
48
Nakaya Y, Mawatari K, Takahashi A, Harada N, Hata A, Yasui S.
The phytoestrogen ginsensoside Re activates potassium channels of vascular smooth muscle cells through PI3K/Akt and nitric oxide pathways.
J Med Invest.
2007;
54(3–4)
381-384
-
49
Maxey T S, Fernandez L G, Reece T B, Keeling W B, Kron I L, Laubach V E.
Endothelial nitric oxide synthase is essential for postpneumonectomy compensatory vasodilation.
Ann Thorac Surg.
2006;
81(4)
1234-1238
-
50
Sorenson J, Santhanam A V, Smith L A, Akiyama M, Sessa W C, Katusic Z S.
Expression and function of recombinant S1179D endothelial NO synthase in human pial arteries.
Stroke.
2005;
36(1)
158-160
-
51
Stanley K P, Chicoine L G, Young T L et al..
Gene transfer with inducible nitric oxide synthase decreases production of urea by arginase in pulmonary arterial endothelial cells.
Am J Physiol Lung Cell Mol Physiol.
2006;
290(2)
L298-L306
-
52
Afsharimani B, Moezi L, Sadeghipour H et al..
Effect of chronic lithium administration on endothelium-dependent relaxation of rat mesenteric bed: role of nitric oxide.
Can J Physiol Pharmacol.
2007;
85(10)
1038-1046
-
53
Viol A W, Prewitt R L, Doviak M, Britt L D.
Endotoxin releases a substance from the aorta that dilates an isolated arteriole by up-regulating INOS.
J Surg Res.
2005;
127(2)
106-111
Feng ZhangM.D. Ph.D.
Division of Plastic Surgery, University of Mississippi Medical Center
2500 North State Street, Jackson, MS 39216
eMail: fzhang@surgery.umsmed.edu
